Effect of daily caffeine consumption on dose of dexmedetomidine for inducing sedation during spinal anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0005686

Enrollment

Registered

2020-12-22

Start date

2020-12-21

Completion date

Unknown

Last updated

2021-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Dexmedetomidine, 1mcg/kg, once, 20minutes, intravenous

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Scheduled surgery under spinal anesthesia ASA PS 1-3 19-70 years

Exclusion criteria

Exclusion criteria: Contraindication in regional anesthesia Taking CNS drugs Currently in severe pain With liver or kidney disease With cardiovascular, respiratory, nervous system disease Conversion to general anesthesia High level block of T4 or higher

Design outcomes

Primary

Measure	Time frame
The amount of dexmedetomidine required to achieve BIS 70 based on daily caffeine intake	—

Secondary

Measure	Time frame
Additional midazolam required to become BIS 70	—

Countries

Korea, Republic of

Contacts

Public ContactWoongmo Kim

Chonnam National University Hospital Hwasun Hospital

Outcome results